摘要：上海，2025年9月29日：士卓曼集团今天宣布，集团已向南京市中级人民法院提起两项诉讼，指控北京卡尔斯医疗器械有限公司及卡尔斯（南京）医疗器械有限公司专利侵权及实施不正当竞争行为。两案均已获南京市中级人民法院正式受理。
上海，2025年9月29日：士卓曼集团今天宣布，集团已向南京市中级人民法院提起两项诉讼，指控北京卡尔斯医疗器械有限公司及卡尔斯（南京）医疗器械有限公司专利侵权及实施不正当竞争行为。两案均已获南京市中级人民法院正式受理。
士卓曼集团种植事业部负责人安德里亚·乌茨（Andreas Utz）表示：“20多年来，士卓曼始终深耕中国医疗健康生态系统。通过近30年持续投资研发、本土合作及人才培养，我们在推动高质量创新、专业培训及患者护理等方面做出了巨大贡献。保护我们的研发成果能确保持续不断地为全球临床医生和患者提供尖端的解决方案——对于BLX这类创新产品而言，这一点尤为重要。”
展望未来，士卓曼将继续全力投入中国市场，扩大本土研发、加强教育项目、深化与本土医疗健康合作伙伴的关系。
作为包括士卓曼BLX、TLX在内的多项种植体系统的发明人，奥菲尔·弗罗莫维奇教授（ Prof. Dr. Ophir Fromovich ） 表示： “ 保护知识产权对支持创新驱动型市场至关重要。专利维权有助于维护投资者信心、市场稳定性和全球合作吸引力。身为种植体系统的发明人，我深知保护创新成果的重要性——唯有如此，才能持续提升患者护理水平，推动该领域研发不断进步。”
作为全球牙科解决方案的领导者，士卓曼将因地制宜地向国内引入国际标准。集团也将致力于通过推动真正创新、培育专业人才、维护市场诚信，为中国牙科事业的未来发展贡献力量。
士卓曼集团期待继续与中国合作伙伴携手，共同构建更加健康、更具创新、更以患者为中心的医疗体系。
###
About Straumann Group
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss.
Headquartered in Basel, Switzerland, the Group currently employs close to 12 000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.
Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland
Phone: +41 (0)61 965 11 11
Homepage: www.straumann-group.com
Contacts:
Corporate Communication
E-mail: corporate.communication@straumann.com
Investor Relations
E-mail: investor.relations@straumann.com
Disclaimer
This press release contains forward-looking statements, including statements regarding the beliefs, expectations and assumptions of future results, performance or achievements of Straumann Group, that are based upon information available to Straumann Group as of the date such statements are made. Forward-looking statements are neither historical facts nor assurances of future performance. They may, but need not, be identified by words such as: "anticipate," "intend," "plan," "goal," "believe," "project," "estimate," "expect," "future," "likely," "may," "should," "will" and similar references to future periods or events. Such forward-looking statements reflect the views, beliefs, assumptions and expectations of Straumann Group or its management at the time the statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may be outside of Straumann Group’s control. Such known and unknown risks, uncertainties and other factors underlying forward-looking statements may cause the actual results, performance or achievements of the Group to differ materially from those expressed or implied in this document. Accordingly, you should not rely on any forward-looking statements contained in this press release. Important factors that could cause the Group’s expectations regarding future results, performance or achievements to differ materially from those expressed in a forward-looking statement include, but are not confined to, future global economic conditions, pandemics, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Straumann Group's control. Should one or more of these risks, uncertainties or other factors materialize or should underlying views, beliefs, assumptions or expectations prove incorrect, actual outcomes may vary materially from those forecasted or expected. Straumann Group is providing the information in this release as of the date it is issued and does not undertake any obligation to update any statements as a result of new information, future events or otherwise. This release constitutes neither an offer to sell nor a solicitation to buy any securities.
来源：见问新视
